Restrictions on Conflicts of Interest Transactions and LP Advisory Committee Approval
First written in FY2023. 2 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025AdvancedAnnual report
「Conflicts of interest may arise among the Group, LP investors and other interested parties, particularly the Company's officers and employees. Accordingly, laws and partnership agreements contain preventive measures restricting certain investment activities and transactions by the Group to ensure that such conflicted transactions are not carried out.」
The disclosed preventive measures now also cover allocation of investment opportunities among the private equity, real estate and global tech businesses and GP-investment limits from Fund V onward. - FY2024AdvancedAnnual report
「When making investments or entering into transactions with funds, the Group examines whether conflicts of interest may arise and, where necessary, obtains approval from an advisory committee comprising certain LP investors before proceeding, thereby conducting business cautiously.」
In addition to existing LP advisory committee approval, amounts of GP investments by officers and employees from Fund V onward are submitted to the voluntary Nomination and Compensation Committee for consultation. - FY2023First statedAnnual report
「When making investments or entering into transactions with funds, the Group examines whether conflicts of interest may arise and, where necessary, obtains approval from an advisory committee comprising certain LP investors before proceeding, thereby conducting business cautiously.」
Describes prohibitions on self-dealing and transactions outside ordinary terms, restrictions on simultaneous and equivalent principal investments, and approval by the LP advisory committee.